title: Ticagrelor in the Real World: The Midland Regional Cardiac Network Experience.
authors.forename: Marcus
authors.initials: M
authors.lastname: Lee
authors.forename: Sarah A
authors.initials: SA
authors.lastname: Green
authors.forename: Tina
authors.initials: T
authors.lastname: Cherian
authors.affiliation: Cardiology Department, Waikato Hospital, Hamilton. devling@waikatoDHB.govt.nz.
authors.forename: Gerard
authors.initials: G
authors.lastname: Devlin
mesh_terms: D000241:Adenosine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000368:Aged; D001241:Aspirin / Q000627:therapeutic use; D015331:Cohort Studies; D004417:Dyspnea / Q000139:chemically induced; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D008297:Male; D055118:Medication Adherence; D009203:Myocardial Infarction / Q000628:therapy*; D017060:Patient Satisfaction; D062645:Percutaneous Coronary Intervention; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D058921:Purinergic P2Y Receptor Antagonists / Q000627:therapeutic use*; D012189:Retrospective Studies; D000077486:Ticagrelor
chemical_list: D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D000077486:Ticagrelor; D000241:Adenosine; D001241:Aspirin